OUTSET: Home with Tablo Outcomes (HOME) Registry
This study aims to evaluatie real world outcomes in participants who receive in-home dialysis on the Tablo Hemodialysis System. It is a prospective, multicenter trial for treatment of participants with end stage renal disease in the home setting. Approxiamtely 250 participants will be enrolled at up to 30 sites. Participants will be followed for 12 months.